Cargando…

Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review

HIV-1 pol sequences from antiretroviral therapy (ART)-naive and ART-experienced people living with HIV-1 are fundamental to understanding the genetic correlates and epidemiology of HIV-1 drug resistance (HIVDR). To assess the public availability of HIV-1 pol sequences and ART histories of the indivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rhee, Soo-Yon, Kassaye, Seble G, Jordan, Michael R, Kouamou, Vinie, Katzenstein, David, Shafer, Robert W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095989/ https://www.ncbi.nlm.nih.gov/pubmed/35544100 http://dx.doi.org/10.1016/S2666-5247(21)00250-0

Ejemplares similares

Rapid HIV-1 drug resistance testing in a resource limited setting: the Pan Degenerate Amplification and Adaptation assay (PANDAA)
por: Kouamou, Vinie, et al.
Publicado: (2021)

HIV‐1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates
por: Rhee, Soo‐Yon, et al.
Publicado: (2020)

A4 Development of HIV drug resistance in HIV-infected patients failing second line regimen in Zimbabwe: A public health concern
por: Kouamou, V, et al.
Publicado: (2018)

Insights into HIV-1 Transmission Dynamics Using Routinely Collected Data in the Mid-Atlantic United States
por: Kassaye, Seble G., et al.
Publicado: (2022)

HIV-1 evolution and drug resistance among patients receiving antiretroviral therapy in San Mateo county, California, 1997-2006
por: Dalai, Sudeb, et al.
Publicado: (2010)

Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation
por: Varghese, Vici, et al.
Publicado: (2010)

Low Prevalence of Pre-Treatment and Acquired Drug Resistance to Dolutegravir among Treatment Naïve Individuals Initiating on Tenofovir, Lamivudine and Dolutegravir in Zimbabwe
por: Kouamou, Vinie, et al.
Publicado: (2023)

Recommendations on data sharing in HIV drug resistance research
por: Inzaule, Seth C., et al.
Publicado: (2023)

Surveillance of Transmitted Antiretroviral Drug Resistance among HIV-1 Infected Women Attending Antenatal Clinics in Chitungwiza, Zimbabwe
por: Tshabalala, Mqondisi, et al.
Publicado: (2011)

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2021)

Genetic Variability of HIV-1 for Drug Resistance Assay Development
por: Clutter, Dana S., et al.
Publicado: (2016)

Geographically-stratified HIV-1 group M pol subtype and circulating recombinant form sequences
por: Rhee, Soo-Yon, et al.
Publicado: (2018)

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis
por: Avila-Rios, Santiago, et al.
Publicado: (2016)

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
por: Feder, Alison F, et al.
Publicado: (2016)

Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2023)

Viral load care of HIV-1 infected children and adolescents: A longitudinal study in rural Zimbabwe
por: Mapangisana, Tichaona, et al.
Publicado: (2021)

Correction: More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
por: Feder, Alison F, et al.
Publicado: (2017)

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance
por: Gifford, Robert J., et al.
Publicado: (2009)

Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease
por: Boyd, Kathryn, et al.
Publicado: (2022)

Clinic-based SAMBA-II vs centralized laboratory viral load assays among HIV-1 infected children, adolescents and young adults in rural Zimbabwe: A randomized controlled trial
por: Kouamou, Vinie, et al.
Publicado: (2023)

Effects of repeated blood donation on iron status of blood donors in Zimbabwe: A cross‐sectional study
por: Vhanda, Donald, et al.
Publicado: (2021)

SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity
por: Kouamou, Vinie, et al.
Publicado: (2021)

A 28-Year History of HIV-1 Drug Resistance and Transmission in Washington, DC
por: Gibson, Keylie M., et al.
Publicado: (2019)

HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
por: Blanco, Jose-Luis, et al.
Publicado: (2011)

The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data
por: Kantor, Rami, et al.
Publicado: (2005)

Corrigendum: A 28-Year History of HIV-1 Drug Resistance and Transmission in Washington, DC
por: Gibson, Keylie M., et al.
Publicado: (2019)

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
por: Reuman, Elizabeth C., et al.
Publicado: (2010)

HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing
por: Tao, Kaiming, et al.
Publicado: (2023)

Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy
por: Tzou, Philip L., et al.
Publicado: (2018)

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
por: Bennett, Diane E., et al.
Publicado: (2009)

Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
por: Tao, Kaiming, et al.
Publicado: (2023)

1731 Medicalizing Prevention: Divergent Views of HIV+ and HIV- Women on PrEP and TasP
por: Goparaju, Lakshmi, et al.
Publicado: (2014)

Improving HIV Surveillance Data for Public Health Action in Washington, DC: A Novel Multiorganizational Data-Sharing Method
por: Ocampo, Joanne Michelle F, et al.
Publicado: (2016)

A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes
por: Doherty, Kathleen M, et al.
Publicado: (2011)

HIV-1 Subtype B Protease and Reverse Transcriptase Amino Acid Covariation
por: Rhee, Soo-Yon, et al.
Publicado: (2007)

Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort
por: Jair, Kamwing, et al.
Publicado: (2019)

The transient effect of a peer support intervention to improve adherence among adolescents and young adults failing antiretroviral therapy in Harare, Zimbabwe: a randomized control trial
por: Ndhlovu, Chiratidzo E., et al.
Publicado: (2021)

Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000–2016: A Pooled Sequence Analysis
por: Chimukangara, Benjamin, et al.
Publicado: (2019)

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing
por: Rhee, Soo-Yon, et al.
Publicado: (2015)

Exploring the use of mobile phone technology for the enhancement of the prevention of mother-to-child transmission of HIV program in Nyanza, Kenya: a qualitative study
por: Jennings, Larissa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_trh9ovdq4ov75v18ofj7la1vbj